Company news
Premier Health Of America Inc (TSXV:PHA) news
Premier Health Of America Inc news releases on 6ix. Latest, Jul 14, 2026: Closing of Previously Announced Restructuring Transaction in Connection with CCAA…
Press releases & updates
Closing of Previously Announced Restructuring Transaction in Connection with CCAA Proceedings
July 13, 2026
Court Approval of a Restructuring Transaction Allowing Continuation of Uninterrupted Operations
July 3, 2026
Premier Health of America Obtains Creditor Protection Under The CCAA-Operations to Continue Without Interruption
June 23, 2026
Premier Health of America Announces CCAA Proceedings
June 23, 2026
Premier Health of America Provides Update on Management Cease Trade Order
June 17, 2026
Premier Health of America Announces Grant of Management Cease Trade Order
June 5, 2026
Premier Health of America Announces Anticipated Delay in Filing Interim Financial Statements and Application for Management Cease Trade Order
June 2, 2026
Premier Health Announces Termination of Forbearance Agreements With Principal Lenders and the Continuance of Its Strategic Review Process
May 8, 2026
Premier Health Announces Management Transition
April 21, 2026
Premier Health Reports 2026 First Quarter Results
February 25, 2026
Premier Health Reports 2025 Fourth Quarter Results
January 27, 2026
Premier Health Reports AMP Decision Regarding Subsidiaries in Quebec
October 2, 2025
Premier Health Reports 2025 Third Quarter Results
August 21, 2025
Premier Health Announces a Strategic Review Process to Enhance Shareholder Value
June 19, 2025
Premier Health Announces CFO Transition
May 26, 2025
Premier Health Reports 2025 Second Quarter Results
May 21, 2025
Premier Health Announces Results of Shareholders' Meeting
May 1, 2025
Premier Health Announces CEO Departure
March 27, 2025
Premier Health Reports 2025 First Quarter Results
February 28, 2025
IIROC Trading Resumption - PHA
April 7, 2022
IIROC Trading Halt - PHA
April 7, 2022
/R E P E A T -- Braxia Scientific to Present at the Psychedelics in Psychiatry and Beyond Virtual Conference Hosted by H.C. Wainwright & Co. on June 17, 2021/
June 16, 2021
Advisory - Multiple lots of irbesartan, losartan and valsartan drugs recalled due to azido impurity
June 15, 2021
Lilly announces new clinical data from Verzenio and oral SERD programs at the American Society of Clinical Oncology annual meeting
June 14, 2021
Tennessee Court Of Appeals Issues Orders Regarding State Court Default Judgment Against Endo
June 11, 2021
Sanofi Canada awards first annual Biogenius Grants, strengthening equity in STEM learning for Canadian students
June 10, 2021
MindMed Announces Chief Executive Officer Transition
June 9, 2021
Kaiser Day Cannaceuticals Signs Production Agreement with Northern Green Inc.
June 8, 2021
Moderna and Medison Pharma partner to commercialize Moderna's COVID-19 vaccine across Central Eastern Europe and Israel
June 7, 2021
Samsung Pharm & GemVax present pancreatic cancer immunotherapeutic drug, RIAVAX(TM), phase III results at ASCO 2021
June 5, 2021
Neighbourly Announces Closing of Over-Allotment Option in connection with Initial Public Offering
June 4, 2021
WCPGHAN 2021: Fish oil taken during pregnancy boosts problem-solving and concentration in children, new data reveals
June 3, 2021
Global Engineering Leader Selects Kneat's SaaS Platform
June 2, 2021
Health Canada Approves ABECMA(TM) (idecabtagene vicleucel), the First and Only Anti-BCMA CAR T cell Therapy for Relapsed and Refractory Multiple Myeloma
May 31, 2021
Qynapse reaffirms its commitment to research in Multiple Sclerosis and is pleased to announce new projects to advance research and clinical care for MS patients
May 30, 2021
Tetra Bio-Pharma Announces Voting Results of 2021 Annual General and Special Meeting
May 28, 2021
COVID-19 - Lancet Respiratory Medicine publishes the Montreal Heart Institute's COLCORONA study
May 27, 2021
Premier Health Signs Agreement in Principle to Acquire Code Bleu Placement en Santé
August 4, 2020
IIROC Trading Resumption - PHA (formerly, PSN.P)
March 2, 2020
Physinorth Provides Qualifying Transaction Details
July 3, 2019
Physinorth Acquisition Corporation Inc. Announces Proposed Qualifying Transaction with Groupe Premier Soin
February 11, 2019
IIROC Trading Halt - PSN.P
February 8, 2019
IIROC Trading Resumption - PSN.P
December 24, 2018
Physinorth Acquisition Corporation Inc. announces the closing of its initial public offering
December 24, 2018
TSX Venture Exchange - Trading Remain Halted - Poseidon Capital Corp. - PSN.P
July 29, 2005
TSX Venture Exchange - Trading Halt - Poseidon Capital Corp. - PSN.P
July 21, 2005